Re: OTC Expert & Grey Market Restrictions
in response to
by
posted on
Nov 22, 2022 10:41AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Dunno. Last day to buy and sell? I guess we'll know tomorrow.